-+ 0.00%
-+ 0.00%
-+ 0.00%

*Edwards Lifesciences: Based on 2Q Performance, Edwards Is Increasing Full-Yr 2026 Sales Growth Rate Guidance to 10% to 11% From 9% to 11% >EW

Dow Jones·07/23/2026 20:19:00

Please log in to view news